Get the Stockscreener App
35.85
1.94%
-0.71
After Hours:
35.91
0.06
+0.17%
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $35.85, with a volume of 3.91M.
It is down -1.94% in the last 24 hours and up +17.16% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
See More
Previous Close:
$36.56
Open:
$36.44
24h Volume:
3.91M
Relative Volume:
0.84
Market Cap:
$18.30B
Revenue:
$17.28B
Net Income/Loss:
$108.00M
P/E Ratio:
179.25
EPS:
0.2
Net Cash Flow:
$391.00M
1W Performance:
+3.05%
1M Performance:
+17.16%
6M Performance:
-8.71%
1Y Performance:
-17.55%
1-Day Range:
$35.68
$36.57
1-Week Range:
$34.72
$37.74
52-Week Range:
$28.34
$43.99
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(847) 948-2000
Address
ONE BAXTER PKWY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
35.85 | 18.30B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
493.72 | 176.09B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
224.92 | 64.58B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
89.15 | 44.10B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
225.79 | 33.17B | 4.93B | 1.25B | 1.38B | 8.47 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
June 2026 Options Now Available For Baxter International (BAX) - Nasdaq
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Position Trimmed by Cullen Frost Bankers Inc. - MarketBeat
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Barclays Boosts Baxter International (NYSE:BAX) Price Target to $41.00 - MarketBeat
E Fund Management Co. Ltd. Invests $339,000 in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. (NYSE:BAX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq - MSN
Baxter at TD Cowen Conference: Strategic Shifts and Growth Ambitions - Investing.com
Baxter warns on certain infusion pumps with missing screws - Drug Delivery Business News
FDA Baxter Healthcare Recalled Spectrum Infusion Pumps Due To Potential For Missing Motor Mounting Screws One Serious Injury Reported - Marketscreener.com
Immunoglobulin Market to Witness Massive Growth by 2032 | Baxter - openPR
HIMSS25: Baxter debuts voice-activated wearable device for hospital clinical teams - Fierce healthcare
Early Alert: Infusion Pump Issue from Baxter Healthcare Corporation - FDA.gov
Global Operating Room Equipment Market is Predicted to Cross ~USD 40 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Baxter International (NYSE:BAX) Unveils Voalte Linq Voice-Activated Tech for Enhanced Patient Care - Simply Wall St
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings - Business Wire
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of “Hold” by Brokerages - Defense World
BAX LAWSUIT ALERT: Levi & Korsinsky Notifies Baxter International Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Baxter International Inc. (NYSE:BAX) Shares Purchased by Bank of New York Mellon Corp - MarketBeat
Baxter International (NYSE:BAX) Earns Buy Rating from Analysts at The Goldman Sachs Group - MarketBeat
Argus Upgrades Baxter International (NYSE:BAX) to Buy - MarketBeat
Handelsbanken Fonder AB Purchases 73,473 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
New York State Common Retirement Fund Boosts Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Ex-Dividend Reminder: Baxter International, Bank of Hawaii and Evercore - Nasdaq
Demystifying Baxter Intl: Insights From 4 Analyst Reviews - Benzinga
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc. (BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Goldman Sachs reinstates Baxter stock with Buy, sets $42 target By Investing.com - Investing.com South Africa
Goldman Sachs reinstates Baxter stock with Buy, sets $42 target - Investing.com
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & SuppliesDiversified Segment - The Globe and Mail
Baxter CFO Set to Reveal Strategic Insights at Major Healthcare Conference Next Year - StockTitan
Plasma Expander Market Set to Witness Significant Growth by 2025-2032 | Baxter International, Fresenius SE & - EIN News
Why Baxter International Inc. (BAX) Are Skyrocketing - Insider Monkey
Baxter International's SWOT analysis: medical supplies giant faces industry shifts By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Lowers Baxter International (NYSE:BAX) Price Target to $36.00 - MarketBeat
Baxter International's SWOT analysis: medical supplies giant faces industry shifts - Investing.com
Baxter International (NYSE:BAX) Issues FY 2025 Earnings Guidance - MarketBeat
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):